Liver Cancer

Search results

• Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

  Friedman, S.

  20/05/24

  1 item of Media coverage

  Press/Media

• Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

  Friedman, S.

  17/05/24

  1 item of Media coverage

  Press/Media

• US SECTOR DAILY: PRESS RELEASES OF LISTED COMPANIES IN THE BIOTECHNOLOGY SECTOR FRIDAY MAY 17, 2024

  Friedman, S.

  17/05/24

  1 item of Media coverage

  Press/Media

• Sagimet Biosciences To Host Virtual Investor And Analyst Day On Inhibiting Fatty Acid Synthase (FASN) To Reduce Liver Fat, Inflammation And Fibrosis In MASH On May 23, 2024

  Friedman, S.

  16/05/24

  1 item of Media coverage

  Press/Media

• Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

  Friedman, S.

  16/05/24

  1 item of Media coverage

  Press/Media

• StreetEasy, Zillow join fight to reshape NYC broker fees

  Friedman, S.

  16/05/24

  1 item of Media coverage

  Press/Media

• Sagimet Biosciences To Host Virtual Investor And Analyst Day On Inhibiting Fatty Acid Synthase (FASN) To Reduce Liver Fat, Inflammation And Fibrosis In MASH On May 23, 2024

  Friedman, S.

  16/05/24

  78 items of Media coverage

  Press/Media

• Findings in the Area of Chronic Liver Disease Reported from Northwestern University (Imaging-based Non-invasive Liver Disease Assessment for Staging Liver Fibrosis In Chronic Liver Disease: a Systematic Review Supporting the Aasld Practice ...)

  Taouli, B.

  16/05/24

  1 item of Media coverage

  Press/Media

• StreetEasy, Zillow join fight to reshape NYC broker fees

  Friedman, S.

  16/05/24

  1 item of Media coverage

  Press/Media

• Mediar Advances First-in-Class Fibrosis Portfolio to the Clinic with First Cohort Dosing in Phase 1 trial of MTX-463 & Establishes Clinical Advisory Board

  Friedman, S.

  9/05/24

  1 item of Media coverage

  Press/Media

• Mediar begins patient dosing in US FDA approved phase 1 trial of MTX-463

  Friedman, S.

  7/05/24

  2 items of Media coverage

  Press/Media

• Mediar begins patient dosing in US FDA approved phase 1 trial of MTX-463

  Friedman, S.

  6/05/24 → 7/05/24

  2 items of Media coverage

  Press/Media

• Mediar Advances First-in-Class Fibrosis Portfolio to the Clinic with First Cohort Dosing in Phase 1 trial of MTX-463 and Establishes Clinical Advisory Board

  Friedman, S.

  6/05/24

  77 items of Media coverage

  Press/Media

• Study Findings from Icahn School of Medicine at Mount Sinai Broaden Understanding of Chronic Kidney Disease [Chronic Kidney Disease In a Murine Model of Non-alcoholic Steatohepatitis (Nash)]

  Zhong, F., Wei, C., Lee, K. & Friedman, S.

  23/04/24

  1 item of Media coverage

  Press/Media

• Research from Icahn School of Medicine at Mount Sinai Has Provided New Data on Metabolic Syndrome (Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome)

  Friedman, S.

  19/04/24

  1 item of Media coverage

  Press/Media

• Radiologists from Across the Country Convene for Canada's Premier Radiology Event

  Taouli, B.

  10/04/24

  1 item of Media coverage

  Press/Media

• Radiologists from Across the Country Convene for Canada's Premier Radiology Event

  Taouli, B.

  9/04/24

  5 items of Media coverage

  Press/Media

• Announcing the 2023 IRE Award winners & finalists

  Friedman, S.

  5/04/24

  1 item of Media coverage

  Press/Media

• Data on Kidney Cancer Described by Researchers at Icahn School of Medicine at Mount Sinai (Characterization of Renal Masses With Mri-based Radiomics: Assessment of Inter-package and Inter-observer Reproducibility In a Prospective Pilot Study)

  Badani, K., Lewis, S., Taouli, B., Bane, O. & Horowitz, A.

  1/04/24

  1 item of Media coverage

  Press/Media

• Madrigal to grapple with lack of awareness about NASH ahead of potential FDA approval

  Friedman, S.

  12/03/24

  1 item of Media coverage

  Press/Media

• ECM Pharmacology Congress x Nordic Bioscience Online Symposium: Fibrosis as a Driver of Cancer, Liver, and Heart-related Outcomes

  Friedman, S.

  11/03/24

  1 item of Media coverage

  Press/Media

• For Unresectable Liver Cancer, the Addition of Durvalumab and Bevacizumab Boosts Efficacy of Transarterial Chemoembolization

  Llovet, J.

  23/02/24

  1 item of Media coverage

  Press/Media

• New Findings from Icahn School of Medicine at Mount Sinai Update Understanding of Liver Cancer (Wntinib Is a Multi-kinase Inhibitor With Specificity Against B-catenin Mutant Hepatocellular Carcinoma)

  Schwarz, M., Torre, D., Lujambio, A., Khan, Z., Llovet, J., Jin, J., Guccione, E., Villanueva Rodriguez, A., Dar, A. & Lujambio Goizueta, A.

  21/02/24

  1 item of Media coverage

  Press/Media

• Research on Hepatitis C Virus Described by a Researcher at Icahn School of Medicine at Mount Sinai (Imprinted immune abnormalities in liver transplant patients cured of hepatitis C with antiviral drugs)

  Kim-Schulze, S., Rahman, A., Schiano, T. & Branch, A.

  15/02/24

  1 item of Media coverage

  Press/Media

• Recent Studies from Icahn School of Medicine at Mount Sinai Add New Data to Vitamin D Deficiency (A Prospective Open-label Dose-response Study To Correct Vitamin D Deficiency In Cirrhosis)

  Bowman-Zamora, C., Schiano, T. & Branch, A.

  13/02/24

  1 item of Media coverage

  Press/Media